Reference
NICE. NICE would welcome further discussions about access to spinal muscular atrophy drug nusinersen Internet Document : 14 Aug 2018. Available from: URL: https://www.nice.org.uk/news/article/nice-would-welcome-further-discussions-about-access-to-spinal-muscular-atrophy-drug-nusinersen
Rights and permissions
About this article
Cite this article
NICE engaging with Biogen over high cost of nusinersen. PharmacoEcon Outcomes News 810, 38 (2018). https://doi.org/10.1007/s40274-018-5229-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5229-z